Cargando…

Impact of COVID-19 on global HCV elimination efforts

BACKGROUND & AIMS: Coronavirus disease 2019 (COVID-19) has placed a significant strain on national healthcare systems at a critical moment in the context of hepatitis elimination. Mathematical models can be used to evaluate the possible impact of programmatic delays on hepatitis disease burden....

Descripción completa

Detalles Bibliográficos
Autores principales:	Blach, Sarah, Kondili, Loreta A., Aghemo, Alessio, Cai, Zongzhen, Dugan, Ellen, Estes, Chris, Gamkrelidze, Ivane, Ma, Siya, Pawlotsky, Jean-Michel, Razavi-Shearer, Devin, Razavi, Homie, Waked, Imam, Zeuzem, Stefan, Craxi, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411379/ https://www.ncbi.nlm.nih.gov/pubmed/32777322 http://dx.doi.org/10.1016/j.jhep.2020.07.042

Ejemplares similares

The impact of immigration on hepatitis B burden in the United States: a modelling study
por: Razavi-Shearer, Devin, et al.
Publicado: (2023)

Optimization of hepatitis C virus screening strategies by birth cohort in Italy
por: Kondili, Loreta A., et al.
Publicado: (2020)

HCV elimination among people who inject drugs. Modelling pre- and post–WHO elimination era
por: Gountas, Ilias, et al.
Publicado: (2018)

Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models
por: de Villiers, Margaret J., et al.
Publicado: (2020)

Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: Pathways to regain progress
por: Blach, Sarah, et al.
Publicado: (2023)

Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
por: Müllhaupt, Beat, et al.
Publicado: (2018)

Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID‐19
por: Blach, Sarah, et al.
Publicado: (2021)

Will the COVID-19 pandemic affect HCV disease burden?
por: Kondili, Loreta A., et al.
Publicado: (2020)

Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions
por: Rosato, Valerio, et al.
Publicado: (2022)

HCV infection prevalence in a population recruited at health centers in Jordan
por: Hamoudi, Waseem, et al.
Publicado: (2013)

Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation
por: Marcellusi, Andrea, et al.
Publicado: (2021)

Chronic Hepatitis C Virus (HCV) Disease Burden and Cost in the United States
por: Razavi, Homie, et al.
Publicado: (2013)

Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach
por: Busschots, Dana, et al.
Publicado: (2022)

Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden
por: Hajarizadeh, Behzad, et al.
Publicado: (2016)

HCV disease burden and population segments in Switzerland
por: Bihl, Florian, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey
por: Kondili, Loreta A., et al.
Publicado: (2022)

Cost-effectiveness modelling of birth and infant dose vaccination against hepatitis B virus in Ontario from 2020 to 2050
por: Biondi, Mia J., et al.
Publicado: (2023)

Forecasting Hepatitis C liver disease burden on real‐life data. Does the hidden iceberg matter to reach the elimination goals?
por: Kondili, Loreta A., et al.
Publicado: (2018)

Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model — Tashkent, Uzbekistan, December 6, 2019–March 15, 2020
por: Dunn, Rick, et al.
Publicado: (2020)

A mathematical model by route of transmission and fibrosis progression to estimate undiagnosed individuals with HCV in different Italian regions
por: Kondili, Loreta A., et al.
Publicado: (2022)

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
por: Estes, Chris, et al.
Publicado: (2017)

Disease burden of hepatitis C in the Austrian state of Tyrol – Epidemiological data and model analysis to achieve elimination by 2030
por: Schaefer, Benedikt, et al.
Publicado: (2018)

Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals
por: Gountas, Ilias, et al.
Publicado: (2019)

Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways
por: Mangia, Alessandra, et al.
Publicado: (2021)

Hepatitis C Virus Micro-Elimination Plan in Southern Italy: The “HCV ICEberg” Project
por: Coppola, Carmine, et al.
Publicado: (2023)

Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model
por: Binka, Mawuena, et al.
Publicado: (2020)

Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis
por: Marcellusi, Andrea, et al.
Publicado: (2021)

Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland
por: Müllhaupt, Beat, et al.
Publicado: (2015)

A tool to measure the impact of inaction toward elimination of hepatitis C: A case study in Korea
por: Won, Yong Kyun, et al.
Publicado: (2020)

A micro-elimination approach to addressing hepatitis C in Turkey
por: Idilman, Ramazan, et al.
Publicado: (2020)

Egypt's Ambitious Strategy to Eliminate Hepatitis C Virus: A Case Study
por: Hassanin, Ahmed, et al.
Publicado: (2021)

The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals
por: Popping, Stephanie, et al.
Publicado: (2019)

High sustained viral response among HCV genotype 3 patients with advanced liver fibrosis: real-world data of HCV elimination program in Georgia
por: Butsashvili, Maia, et al.
Publicado: (2020)

HBV and HCV Therapy
por: Lampertico, Pietro, et al.
Publicado: (2009)

Urgent action to fight hepatitis C in people who inject drugs in Europe
por: Dillon, John F., et al.
Publicado: (2016)

Nonalcoholic fatty liver disease burden: Australia, 2019–2030
por: Adams, Leon A, et al.
Publicado: (2020)

Is HCV elimination possible in prison?
por: Crespo, J., et al.
Publicado: (2017)

Remaining challenges in HCV elimination
por: Capraru, Camelia, et al.
Publicado: (2021)

Virologic Tools for HCV Drug Resistance Testing
por: Fourati, Slim, et al.
Publicado: (2015)

The Payer License Agreement, or “Netflix model,” for hepatitis C virus therapies enables universal treatment access, lowers costs and incentivizes innovation and competition
por: Matthews, David W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a3hgptbj5fpm07e623va72gnvk